Revance(US:RVNC) Prnewswire·2025-01-10 10:45Class Action Lawsuit Details - The lawsuit seeks to recover losses for Revance investors affected by alleged securities fraud between February 29, 2024, and December 6, 2024 [1] - Investors have until March 4, 2025, to request appointment as lead plaintiff [3] Allegations Against Revance - Revance allegedly breached the Distribution Agreement with Teoxane, which granted exclusive rights to import, market, promote, sell, and distribute Teoxane's dermal fillers [2] - The breach increased the risk of litigation, monetary harm, reputational damage, and potential delays or amendments to the tender offer [2] - Revance's public statements during this period are alleged to have been materially false and misleading [2] Legal Representation - Levi & Korsinsky, LLP has secured hundreds of millions of dollars for aggrieved shareholders over the past 20 years [4] - The firm has been ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years [4] - Levi & Korsinsky employs over 70 professionals and specializes in complex securities litigation [4]